Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Start Date
2/16/2016
Completion Date
12/31/2026
Summary
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Detailed Description
This is an observational study only for all consented subjects who undergo an Exablate treatment. The Exablate procedure is a commercial treatment. The objective of this registry is to collect data about the effect of Exablate treatment on potential pregnancy occurrences in this population for two years post-treatment for purposes of labeling updates and overall safety data collection.
Eligibility Criteria
Age Range: 18 years to 50 years
Interventions
Body System - Functional
Conditions
Locations
UCLA
Los Angeles, California 90095
United States
Stanford University
Stanford, California 94305
United States
Mayo Clinic
Rochester, Minnesota 55905
United States
Huashan Hospital Affiliated to Fudan University
Shanghai,
China
Shanghai No. 1 Hospital
Shanghai,
China
Shanghai No.1 Hospital
Shanghai,
China